T1	Participants 147 158	31 patients
T2	Participants 384 396	All patients
T3	Participants 509 725	Seventeen patients received adjuvant chemotherapy consisting of doxorubicin (less than or equal to 550 mg/m2), cyclophosphamide (less than or equal to 5500 mg/m2), and methotrexate (less than or equal to 1000 mg/kg).
T4	Participants 1306 1317	26 patients
T5	Participants 1612 1623	57 patients
T6	Participants 2030 2147	The subgroup of patients with sarcomas of the trunk (39 patients) demonstrated the greatest benefit from chemotherapy
